Experimental study of the influence of a bioresorbable vascular stent platform
DOI:
https://doi.org/10.11603/2414-4533.2022.4.13612Keywords:
bioresorbable vascular stent-platforms, tissue reaction, histological examinationAbstract
The aim of the work: to investigate the effect of bioresorbable vascular stent-platforms «Absorb» (Abbott, USA) on the surrounding tissues in the area of its implantation, as well as the features of resorption of the stent-platform.
Material and Methods. In the study, histological preparations of nine three-month-old white laboratory rats weighing 150-170 g were studied, which were implanted with a fragment of biodegradable vascular stent-platforms in the great omentum and subcutaneously. Animals were removed from the experiment 30, 90, and 180 days after the intervention.
Results and Discussion. During the study of histological preparations in the area of implantation under the skin in the period of 30 and 90 days, and 30 days after implantation in the great omentum, areas of lymphocytic macrophage infiltration and fibrosis of the capsule were found. However, when examining histological preparations of the following periods of the experiment, a significant decrease in the intensity of perifocal inflammatory and vascular reactions with the formation of mostly thin capsules was noted. Also, at 90 and 180 days, structureless material similar to tissue detritus was found on the inner surface of individual capsules, which probably indicates a more pronounced destruction of the stent layers than in the previous periods.
Implantation of stent fragments was not accompanied by a pronounced inflammatory reaction. A gradual increase in focal lymphocytic infiltration in the implantation zone was observed from 30 to 90 days with a significant decrease in the intensity of the latter at 180 days. Macrophage reaction increased in terms of 30 to 180 days, which indicates the benefit of gradual biodestruction of the stent material. Resorption of the stent beams occurred moderately, starting mainly from day 90 with the formation of small granules of foreign bodies with single giant cells of foreign bodies. The use of implants was not accompanied by tissue deformations, seroma formation and other negative consequences. The absence of a pronounced irritating effect indicates biocompatibility with body tissues.
References
Bourantas, C.V., Zhang, Y., Farooq, V., Garcia-Garcia, H.M., Onuma, Y., & Serruys, P.W. (2012). Bioresorbable scaffolds: current evidence and ongoing clinical trials. Current Cardiology Reports, 14, 626-634.
Brugaletta, S., Garcia-Garcia, H.M., Onuma, Y., & Serruys, P.W. (2012). Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives. Expert. Review of Medical Devices, 9(4), 327-338.
Garg, S., & Serruys, P.W. (2010). Coronary stents: current status. Journal of the American College of Cardiology, 56(10S), S1-S42.
Gogas, B.D., van Geuns, R.J., Farooq, V., Regar, E., Heo, J.H., Ligthart, J., & Serruys, P.W. (2011). Three-dimensional reconstruction of the post-dilated ABSORB everolimus-eluting bioresorbable vascular scaffold in a true bifurcation lesion for flow restoration. JACC: Cardiovascular Interventions, 4(10), 1149-1150.
Gomez-Lara, J., Garcia-Garcia, H.M., Onuma, Y., Garg, S., Regar, E., De Bruyne, B., ... Serruys, P.W. (2010). A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents. JACC: Cardiovascular Interventions, 3(11), 1190-1198.
Gomez-Lara, J., Brugaletta, S., Diletti, R., Garg, S., Onuma, Y., Gogas, B.D., ... Serruys, P.W. (2011). A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds. European Heart Journal, 32(3), 294-304.
Gomez-Lara, J., Brugaletta, S., Farooq, V., Onuma, Y., Diletti, R., Windecker, S., ... Serruys, P.W. (2011). Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography. JACC: Cardiovascular Interventions, 4(12), 1271-1280.
Gomez-Lara, J., Radu, M., Brugaletta, S., Farooq, V., Diletti, R., Onuma, Y., ... & Serruys, P.W. (2011). Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography. JACC: Cardiovascular Interventions, 4(9), 992-1001.
Oberhauser, J.P., Hossainy, S., & Rapoza, R.J. (2009). Design principles and performance of bioresorbable polymeric vascular scaffolds. EuroIntervention Supplement., 5, F15-22.
Onuma, Y., Ormiston, J., & Serruys, P.W. (2011). Bioresorbable scaffold technologies. Circulation Journal, 75(3), 509-520.
Serruys, P.W., Ormiston, J.A., Onuma, Y., Regar, E., Gonzalo, N., Garcia-Garcia, H.M., ... Dudek, D. (2009). A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet, 373(9667), 897-910.
Maiborodin, I.V., Kuznetsova, I.V., Shevela, A.I., Barannik, M.I., Manaev, A.A., & Maiborodina, V.I. (2014). Tkanevyie reaktsii pri ispolzovanii implantatov iz polimerov molochnoi kisloty [Tissue reactions during degradation of polylactide implants in the body]. Morfologiya – Morphology, 146(4), 78-89 [in Russian].
Shlyakhtun, A.S., & Shapovalova, Ye.G. (2018). Vliyanie makrofagov na protsess degradatsii polimera [Influence of macrophages on the process of polymer degradation]. Biologiya i fundamentalnaya meditsina – Biology and Fundamental Medicine, 4, 179-181 [in Russian].
Kereiakes, D.J., Ellis, S.G., Metzger, C., Caputo, R.P., Rizik, D.G., & Teirstein, P.S. (2017). 3-year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: the ABSORB III trial. Journal of the American College of Cardiology, 70(23), 2852-2862.
Koh, J.S., Gogas, B.D., Kumar, S., Benham, J.J., Sur, S., Spilias, N., ... & Samady, H. (2021). Very late vasomotor responses and gene expression with bioresorbable scaffolds and metallic drug-eluting stents. Catheterization and Cardiovascular Interventions, 98(4), 723-732.
Serruys, P.W., Chevalier, B., Sotomi, Y., Cequier, A., Carrié, D., Piek, J.J., ... & Onuma, Y. (2016). Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet, 388(10059), 2479-2491.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Hospital Surgery. Journal named by L.Ya. Kovalchuk
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish their work in Hospital Surgery. Journal by L. Ya. Kovalchuk agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
